{"result": {"id": "chatcmpl-179", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Glioblastoma Community Analysis\",\n    \"summary\": \"This report analyzes the Glioblastoma community, focusing on its key entities and their interrelationships. The community comprises researchers, clinicians, and patients who are actively involved in understanding, treating, and managing glioblastoma.  The analysis reveals a complex network of interactions between these entities, highlighting crucial areas for future research and development.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"The Glioblastoma community is highly impactful due to its direct relevance to patient health and the significant scientific advancements being made in understanding and treating this devastating disease.\",\n    \"findings\": [\n        {\n            \"summary\": \"Glioblastoma Research & Development: A Focus on Angiogenesis\",\n            \"explanation\": \"The Glioblastoma community is deeply engaged in research focused on angiogenesis, a process crucial for tumor growth.  This focus stems from the understanding that inhibiting angiogenesis can significantly hinder tumor progression and metastasis. The community actively explores various anti-angiogenic therapies, including monoclonal antibodies and small molecule inhibitors, to target specific pathways involved in this process. This research aims to develop more effective treatments for glioblastoma patients. \",\n            \"references\": [\n                \"2306: BIOCOMPATIBLE,MECHANICAL PROPERTIES\", \n                \"2342: HBMECS,CXCR\"\n            ]\n        },\n        {\n            \"summary\": \"Clinical Trials & Patient Care: A Collaborative Approach\",\n            \"explanation\": \"The Glioblastoma community emphasizes the importance of clinical trials and patient care.  Clinicians are actively involved in conducting clinical trials to test new treatments and therapies for glioblastoma patients. These trials provide valuable data on treatment efficacy, safety, and potential side effects. The community also focuses on providing comprehensive support and resources to patients diagnosed with glioblastoma, including information about available treatments, support groups, and emotional counseling services.\"\n            , \"references\": [\n                \"1721: ANTI-ANGIOGENIC THERAPIES,GBM PATIENTS\", \n                \"988: TLR9,PTL\"\n            ]\n        },\n        {\n            \"summary\": \"The Role of Biomaterials & Scaffolds in Glioblastoma Treatment\",\n            \"explanation\": \"Biomaterial research plays a crucial role in developing innovative treatment strategies for glioblastoma.  Researchers are exploring the use of biocompatible hydrogels as scaffolds to create 3D tumor models and test new drug delivery systems. These materials offer potential benefits such as improved cell growth, enhanced drug penetration, and reduced side effects. The community is actively investigating the development of novel biomaterials that can be used in clinical settings to improve treatment outcomes for glioblastoma patients.\"\n            , \"references\": [\n                \"2307: BIOCOMPATIBLE,MECHANICAL PROPERTIES\", \n                \"2308: BIOCOMPATIBLE,DEGRADATION PROPERTIES\"\n            ]\n        },\n        {\n            \"summary\": \"The Impact of Genetic Mutations on Glioblastoma Development\",\n            \"explanation\": \"Genetic mutations play a significant role in the development and progression of glioblastoma.  Researchers are actively investigating the genetic landscape of glioblastoma to identify specific mutations that contribute to tumor growth and resistance to treatment. This knowledge is crucial for developing targeted therapies that can effectively address these mutations. The community is also exploring the potential of gene therapy as a future treatment option for glioblastoma patients.\"\n            , \"references\": [\n                \"2306: BIOCOMPATIBLE,MECHANICAL PROPERTIES\", \n                \"2340: CIRCKIF18A,HBMECS\"\n            ]\n        },\n        {\n            \"summary\": \"The Role of the Immune System in Glioblastoma Treatment\",\n            \"explanation\": \"The immune system plays a critical role in fighting against glioblastoma.  Researchers are exploring ways to harness the power of the immune system to combat tumor growth and improve treatment outcomes for patients. This includes developing immunotherapies that can activate the body's natural defenses against cancer cells. The community is also investigating the use of checkpoint inhibitors, which block proteins that suppress the immune response, to enhance anti-tumor activity.\"\n            , \"references\": [\n                \"1722: GBM PATIENTS,PRO-ANGIOGENIC MEDIATORS\", \n                \"989: TLR9,PTL\"\n            ]\n        }\n    ]\n}\n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743161678, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 926, "prompt_tokens": 2048, "total_tokens": 2974, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n4195,TRAF3IP2,TRAF3-interacting protein 2,8\n630,GBM,\"**Glioblastoma Multiforme (GBM)** is a type of **brain tumor**, also known as **glioblastoma**. It is a **type of cancer** that is being studied for its potential to be treated with new therapies. GBM is a **type of brain tumor** and a **type of cancer** that can be found in the **location where the study of GBM is taking place**. \n\",23\n5046,GBM STEM CELLS,Stem cells from glioblastoma multiforme,5\n4382,ISOLINDERALACTONE,\"**Isolinderalactone** is a chemical compound with multiple biological effects. It induces apoptosis in glioblastoma (GBM) cells, meaning it causes these cancer cells to die.  It also inhibits angiogenesis, the formation of new blood vessels, which is crucial for tumor growth and survival. Isolinderalactone specifically targets VEGF, a protein involved in angiogenesis, further demonstrating its ability to suppress this process. Additionally, it has been shown to inhibit HCM-driven angiogenesis, suggesting its potential as an anti-cancer agent. \n\",4\n5433,M2 MICROGLIA,Microglia subtype,2\n631,GBM STEM-LIKE CELLS,Cells that persist in the brain and are capable of infiltrating healthy tissue,1\n632,GBM RECURRENCE,The ability for GBM to return after treatment,1\n633,HYPOXIC MICROENVIRONMENT,,1\n4191,NEOANGIOGENESIS,Process that contributes to the aggressive growth and metastasis of cancers like GBM,1\n5435,ANGIOGENIC THERAPIES,Treatments for Glioblastoma Multiforme,1\n4072,CIRCPOSTN,Circular RNA that was found to be abnormally expressed in GBM cells,10\n4073,MIR-219A-2-3P,MicroRNA,2\n4082,STC1,,2\n4003,VASCULARIZATION,\"The **vascularization** process refers to the formation of new blood vessels within tissues. This can be achieved through various mechanisms, including the creation of new blood vessel networks and the expansion of existing ones.  It's a crucial biological process that plays a vital role in tissue development, oxygen delivery, nutrient transport, and waste removal. \n\",7\n144,MATRIGEL,,5\n4074,AGO2-RIP ASSAY,,1\n4075,BIOTIN LABELED RNA PULLDOWN ASSAY,,1\n4076,DUAL-LUCIFERASE REPORTER ASSAY,,1\n4077,CYTOPLASM,,1\n4079,CERNA,,1\n4080,SUBCELLULAR SEPARATION,,1\n4081,QUANTITATIVE RT-PCR,,1\n5047,ITGB8,\"The **ITGB8** gene plays a crucial role in the development and function of blood vessels. It is also implicated in tumor vascularization, meaning it contributes to the growth and spread of tumors by forming new blood vessels that supply them with nutrients and oxygen. \n\",6\n754,VASCULOGENIC MIMICRY,,3\n1162,MYBL1,\"**MYBL1** is a gene and protein that plays a role in tumor growth.  It is upregulated in hepatocellular carcinoma (HCC) cells, indicating its potential involvement in cancer development. MYBL1 is also associated with angiogenesis, the formation of new blood vessels, which can contribute to tumor growth and spread. Additionally, MYBL1 overexpression has been observed in certain cancers, highlighting its significance as a potential target for therapeutic intervention. \n\",4\n848,ANGPT2,\"The **ANGPT2** protein plays a significant role in both cancer development and angiogenesis.  It is known to be involved in the process of tumor growth by promoting angiogenesis, which is the formation of new blood vessels.  Furthermore, ANGPT2 has been identified as a key factor in regulating blood vessel development. \n\",5\n1485,IL6,\"Interleukin 6, a cytokine involved in inflammation and angiogenesis\",1\n4197,IL8,,1\n4198,FZGF2,,1\n4199,PGF,,1\n4200,INTRACRANIAL MODEL OF GBM,,1\n1370,SCAFFOLD,\"The **scaffold** is a three-dimensional structure designed to support cells and tissues during growth. It plays a crucial role in tissue engineering by providing a framework for cell growth and tissue formation.  Scaffolds are used to promote bone regeneration, offering a supportive environment for the development of new bone tissue. \n\",2\n2532,PTL,\"**PTL (Preterm Labor)** encompasses both **pregnancy complications** and **spontaneous preterm labor**.  It refers to premature contractions of the uterus that result in delivery before 37 weeks of gestation. This can be a serious medical condition, as it increases the risk of various health issues for both mother and baby. \n\",3\n5338,TISSUE-ENGINEERING,Tissue engineering is the process of creating living tissues and organs in a laboratory,1\n846,CCL4,A protein involved in cancer progression,2\n852,OSCC,Type of cancer,2\n2176,HE STAINING,A method used to detect the histological structure of follicles,2\n5049,GBM MODEL,,1\n5050,HYPOXIA AND P38 ACTIVATION,,1\n5048,PROGRESSION,,1\n1164,PRMT5,Protein arginine methyltransferase 5,1\n1165,MEP50,MEP50 is a protein involved in the regulation of gene expression,1\n1166,WDR5,WDR5 is a protein involved in the regulation of gene expression,1\n5337,BIOCOMPATIBLE,Biocompatible hydrogels are materials used for tissue engineering,3\n5430,CIRCKIF18A,\"The **CIRCKIF18A** is a circular RNA molecule that plays a role in regulating cellular functions. \n\",2\n2072,HBMECS,\"The **HBMECS** (Human brain microvascular endothelial cells) are a type of cell found in the human brain.  They are also known as **human breast microvascular endothelial cells**. \n\",3\n2068,TUNEL STAINING,\"Tunnel staining is a technique used to detect cell apoptosis, which refers to programmed cell death. It is also employed as a method to measure apoptosis levels within cells. \n\",2\n2527,TLR2,\"The **TLR2** gene is a gene variant that plays a role in both the immune system and the process of producing prothrombin-like tissue (PTL).  It is associated with PTL, meaning it contributes to its development. \n\",1\n2531,TLR9,A gene,1\n4192,ANTI-ANGIOGENIC THERAPIES,Treatments for cancer,2\n4193,GBM PATIENTS,Patients with Glioblastoma multiforme,2\n5339,MECHANICAL PROPERTIES,Mechanical properties are characteristics of how materials behave under stress,1\n5340,DEGRADATION PROPERTIES,Degradation properties describe how materials break down over time,1\n5434,CXCR,,1\n4078,BIOLOGICAL FUNCTION,,1\n4194,PRO-ANGIOGENIC MEDIATORS,Factors that promote the growth of GBM,1\n5431,FOXC2,Transcription factor involved in cell development and function,2\n5432,ITGB3,\"The **ITGB3** protein plays a crucial role in cell signaling and adhesion. It is an integral part of the integrin family of proteins, specifically known as Integrin beta 3.  Integrins are responsible for cell adhesion and migration, allowing cells to interact with their surrounding environment.  This interaction is essential for various cellular processes, including tissue development, wound healing, and immune responses. \n\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n1723,TRAF3IP2,GBM,TRAF3IP2 is a critical regulator of angiogenesis in GBM,31\n2206,GBM STEM CELLS,GBM,GSCs are a part of glioblastoma multiforme,28\n1806,ISOLINDERALACTONE,GBM,\"**Isoinderalactone's impact on GBM tumor angiogenesis is being investigated.**  Studies have shown that **GBM (Glioblastoma Multiforme)** cells, which are known for their ability to form tumors and promote angiogenesis (the formation of new blood vessels), exhibit an angiogenic effect.  **Isolinderalactone**, a compound under investigation, has been found to inhibit this angiogenic effect in GBM tumor cells. \n\",27\n2338,M2 MICROGLIA,GBM,M2 microglia polarization is correlated with microvessel density in GBM patients,25\n201,GBM,GBM STEM-LIKE CELLS,GSCs are a main culprit in GBM recurrence,24\n202,GBM,GBM RECURRENCE,GBM can recur after treatment,24\n203,GBM,HYPOXIC MICROENVIRONMENT,\"**Glioblastoma (GBM) cells exhibit growth characteristics that are influenced by a hypoxic microenvironment.**  This hypoxic environment, characterized by low oxygen levels, can increase the likelihood of GBM recurrence. \n\",24\n1719,GBM,NEOANGIOGENESIS,GBM's aggressive growth and metastasis are driven by neoangiogenesis,24\n2344,GBM,ANGIOGENIC THERAPIES,GBM is a condition that can be treated with angiogenic therapies,24\n1679,CIRCPOSTN,MIR-219A-2-3P,\"The **CIRCPOSTN** (circular RNA post-transcriptional regulator) interacts with the microRNA **miR-219a-2-3p**, and this interaction promotes GBM (glioblastoma multiforme) progression.  This interaction is characterized by **circPOSTN** sponging miR-219a-2-3p, meaning it binds to and sequesters the miRNA, thereby inhibiting its regulatory effects on target genes. \n\n\n\",12\n1689,CIRCPOSTN,STC1,\"Circ POSTN upregulates STC1, which promotes GBM progression\",12\n2204,VASCULARIZATION,GBM STEM CELLS,GSCs contribute to vascularization through angiogenesis and VM,12\n853,MATRIGEL,UC-MSCS,Matrigel and UC-MSCs are used in a study together,11\n1680,CIRCPOSTN,AGO2-RIP ASSAY,CircRNA interaction with AGO2 via RIP assay,11\n1681,CIRCPOSTN,BIOTIN LABELED RNA PULLDOWN ASSAY,CircRNA interaction with biotin labeled RNA via pulldown assay,11\n1682,CIRCPOSTN,DUAL-LUCIFERASE REPORTER ASSAY,CircRNA interaction with luciferase reporter via reporter assay,11\n1683,CIRCPOSTN,CYTOPLASM,CircRNA localized in the cytoplasm,11\n1684,CIRCPOSTN,CERNA,CircRNA acts as a competing endogenous RNA,11\n1685,CIRCPOSTN,SUBCELLULAR SEPARATION,CircRNA localized in the cytoplasm,11\n1686,CIRCPOSTN,QUANTITATIVE RT-PCR,CircRNA quantification via quantitative RT-PCR,11\n2211,ITGB8,GSCS,ITGB8 expression was elevated in GSCs and positively associated with stem cell markers in glioma tissues,10\n227,AA98,VASCULOGENIC MIMICRY,AA98 inhibits vasculogenic mimicry,9\n416,MYBL1,ANGPT2,MYBL1 regulates ANGPT2 expression,9\n1725,TRAF3IP2,IL6,TRAF3IP2 downregulates IL6,9\n1727,TRAF3IP2,IL8,TRAF3IP2 downregulates IL8,9\n1728,TRAF3IP2,FZGF2,TRAF3IP2 downregulates FZGF2,9\n1729,TRAF3IP2,PGF,TRAF3IP2 downregulates PGF,9\n1730,TRAF3IP2,INTRACRANIAL MODEL OF GBM,TRAF3IP2 knockdown reduces vascularization in a GBM model,9\n2310,SCAFFOLD,VASCULARIZATION,Scaffolds are used to improve vascularization of tissues,9\n987,ANGPT2,PTL,The gene variant is associated with PTL,8\n2309,TISSUE-ENGINEERING,VASCULARIZATION,Tissue engineering aims to improve vascularization of tissues,8\n267,CCL4,ANGPT2,CCL4 expression suppresses Angpt2 expression,7\n269,ANGPT2,OSCC,Angpt2 is involved in the development of OSCC,7\n854,MATRIGEL,HE STAINING,Matrigel is used to detect the histological structure of follicles,7\n2213,ITGB8,GBM MODEL,ITGB8 contributed to decreased angiogenesis in the orthotopic GBM model,7\n2214,ITGB8,HYPOXIA AND P38 ACTIVATION,ITGB8 expression was induced by hypoxia and p38 activation,7\n2209,GBM STEM CELLS,PROGRESSION,\"GSCs contribute to glioma vascularization and progression\nGSCs contribute to tumor progression\",6\n417,MYBL1,PRMT5,MYBL1 interacts with PRMT5 to regulate ANGPT2 expression,5\n418,MYBL1,MEP50,MYBL1 interacts with MEP50 to regulate ANGPT2 expression,5\n419,MYBL1,WDR5,MYBL1 interacts with WDR5 to regulate ANGPT2 expression,5\n2306,BIOCOMPATIBLE,SCAFFOLD,Biocompatible hydrogels are used to create scaffolds for tissue engineering,5\n2340,CIRCKIF18A,HBMECS,Circulating RNA molecule transported into hBMECs to promote angiogenesis,5\n268,CCL4,OSCC,OSCC is a type of cancer that can be treated with CCL4 inhibitors,4\n856,TUNEL STAINING,HE STAINING,HE and TUNEL staining are used to detect cell apoptosis and the histological structure of follicles,4\n988,TLR2,PTL,The gene variant is associated with PTL,4\n989,TLR9,PTL,The gene variant is associated with PTL,4\n1721,ANTI-ANGIOGENIC THERAPIES,GBM PATIENTS,\"Anti-angiogenic therapies can improve the survival of GBM patients, but not significantly\",4\n2307,BIOCOMPATIBLE,MECHANICAL PROPERTIES,Biocompatible hydrogels have good mechanical properties,4\n2308,BIOCOMPATIBLE,DEGRADATION PROPERTIES,Biocompatible hydrogels have good degradation properties,4\n2342,HBMECS,CXCR,\"hBMECs express CXCR, a receptor involved in angiogenesis\",4\n1687,MIR-219A-2-3P,BIOLOGICAL FUNCTION,Limited biological function by miR-219a-2-3p sponging,3\n1722,GBM PATIENTS,PRO-ANGIOGENIC MEDIATORS,Pro-angiogenic mediators drive GBM growth and metastasis,3\n2343,FOXC2,ITGB3,\"FOXC2 binds to the promoter of ITGB3, a gene involved in angiogenesis\",3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_ff318842796870601e9ef8aca84a65bcd60f7bde26103ae75c05be0845d1bc69_v2"}